Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

EAACI

Bonifazi F, Jutel M, Bilo BM. Bimbaum J. Muller U EAACI Interest Group on Insect Venom Hypersensitivity Prevention and treatment of Hymenoptera venom allergy guidelines for chnical practice. Allergy 2005 60 1459-1470. [Pg.20]

Turjanmaa K, Darsow U, Niggemann B, Ranee F, Vanto T, Werfel T EAACI/GA2LEN position paper present status of the atopy patch test. Allergy 2006 61 1377-1384. [Pg.109]

The European Academy of Allergology and Clinical Immunology (EAACI) defines a food allergy in the following way (Johansson, 2002) ... [Pg.112]

Johansson, S.G.O. (2002). A revised nomenclature for allergy. A condensed version of the EAACI position statement from the EAACI Nomenclature Task Force, Allergy Clin. Immunol. Int., 14, 279-287. [Pg.123]

Mailing HJ, Weeke B Immunotherapy. EAACI position paper. Allergy 1993 48(suppl 14) 9—30. [Pg.41]

Bousquet J, Mailing H-J, Abreu-Nogueira J, Alvarez-Cuesta E, et al EAACI/ESPACI position paper on local immunotherapy. Allergy 1998 53(suppl 44) 1 42. [Pg.60]

In the 1998 EAACI position paper 6 studies using the sublingual route were identified [1], The authors concluded that SLIT had been shown to be efficacious in patients with rhinitis, but insufficient information was available to draw any conclusions for its use in asthma. [Pg.78]

Passalacqua G, Bagnasco M, Mariani G, Falagiani P, Canonica GW Local immunotherapy Pharmacokinetics and efficacy. EAACI/PTA Symposium Reviews. Allergy 1998 53 477 484. [Pg.98]

As mentioned before, LNIT requires a particular administration technique after premedication, the allergenic extract (aqueous or powdered) has to be sprayed into a nostril while vocalizing. This fact, in addition to the efficacy limited to the nose, reduced the clinical use of LNIT therefore, no postmarketing surveillance studies are available. In conclusion, based on the clinical trials, LNIT appears safe and well tolerated. The EAACI/ESPACI position paper states that side effects do not represent a problem [12],... [Pg.115]

Mailing HJ EAACI position paper on local immunotherapy. Allergy 1998 53 933-944. [Pg.116]

Khinchi S, Poulsen LK, Carat F, Andre C, Mailing HJ Clinical efficacy of sublingual swallow and subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis due to birch pollen. A double-blind double-dummy placebo-controlled study. 19th EAACI Congress, Lisbon (abstract). Allergy 2000 55(suppl 63) 24. [Pg.118]

Mailing H Immunotherapy. Position paper of the EAACI. Allergy 1988 43(suppl 6) 228—238. [Pg.125]

Johansson, S. G. O., Hourihane, J. O. B., Bousquet, J. et al. 2001. Position paper. A revised nomenclature for allergy An EAACI position statement from the EAACI nomenclature task force. Allergy 9 813-829. [Pg.37]

Tumjamaa, K., Darsow, U., Niggemann, B. et al. 2006. EAACI/GA2 LEN Position Paper Present status of the atopy patch tests. Position paper of the Section on Dermatology and the section on Pediatrics of the European Academy of Allergy and Clinical Immunology. Allergy 61 1377-1384. [Pg.145]

Stapel, S. O., R. Asero, B. K. Ballmer-Weber, E. F. Knol, S. Strobel, S. Vieths, and J. Kleine-Tebbe. 2008. Testing for IgG4 against foods is not recommended as a diagnostic tool EAACI Task Force Report. Allergy 63 (7) 793—796. [Pg.183]

DDBJ—see EMBL DLS—dynamic light scattering DM—donkey s milk DNA—deoxyribonucleic acid DNCB—2,4-dinitrochlorobenzene DSC—differential scanning calorimetry DTH—delayed cellular hypersensitivity DXMS—deuterium exchange mass spectrometry EAACI—European Academy of Allergology and Clinical Immunology EAR—early anaphylactic phase ECFA—eosinophil chemotactic factors of anaphylaxis ECP—eosinophil cationic protein EDN—eosinophil-derived neurotoxin eHF—extensively hydrolyzed formula ELISA—enzyme-linked immunosorbent assay... [Pg.449]

Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C, Nagy L, Szemere P, Davies RJ, Durham SR, Horak F, Kontou-FUi K, Mailing HJ, van Cauwenberge P, Canonica GW. The clinical safety of Hl-receptor antagonists. An EAACI position paper. Allergy 1996 51(10) 666-75. [Pg.314]

Schultz K, Stell WK (1996) Immunocytochemical localization of the high-affinity glutamate transporter, EAACI, in the retina of representative vertebrate species. Neurosci Lett 2// 191-194. [Pg.253]


See other pages where EAACI is mentioned: [Pg.178]    [Pg.112]    [Pg.110]    [Pg.111]    [Pg.174]    [Pg.226]    [Pg.228]    [Pg.254]    [Pg.267]    [Pg.5]    [Pg.5]    [Pg.128]    [Pg.37]   


SEARCH



EAACI Clinical Immunology

© 2024 chempedia.info